IP Library Granted Patent US 7,407,983
Granted Patent B2
US 7,407,983 · App. 10/504,484 · Granted Aug 5, 2008

Indole derivatives substituted with long-chain alcohols and medicaments containing them

Assignee: Meiji Dairies Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,407,983
App. No.
10/504,484
Granted
Aug 5, 2008
Kind
B2
Abstract

Provided is an indole long-chain alcohol, or a hydrate or an isomer thereof, represented by the following formula (I): wherein R 1 , R 2 , R 3 and R 4 each independently represent a hydrogen atom, a methyl group, an acetyl group, or a hydroxyl group, and n represents a number from 0 to 20; and a medicinal composition comprising the same. The indole long-chain alcohol (I) exhibits an excellent nerve growth promoting effect, as well as potent antioxidative and anti-tumor effects, and is therefore useful as a prophylactic and/or therapeutic agent for cerebral diseases including dementia diseases, and malignant tumors including brain tumors.

Claims (27)

1. An indole long-chain alcohol, or a hydrate or an isomer thereof, according to the following formula (I):

wherein R 1 , R 2 , R 3 , and R 4 each independently represent a hydrogen atom, a methyl group, an acetyl group, or a hydroxyl group, and n represents a number from 10 to 20.

2. The indole long-chain alcohol according to claim 1 , wherein n represents a number from 12 to 20.

3. The indole long-chain alcohol according to claim 1 , wherein n represents a number from 14 to 20.

4. The indole long-chain alcohol according to claim 1 , wherein n represents a number from 16 to 20.

5. The indole long-chain alcohol according to claim 1 , wherein n represents a number from 18 to 20.

6. The indole long-chain alcohol according to claim 1 , wherein n represents a number from 10 to 14.

7. The indole long-chain alcohol according to claim 1 , wherein n represents a number from 12 to 16.

8. The indole long-chain alcohol according to claim 1 , wherein n represents a number from 14 to 18.

9. The indole long-chain alcohol according to claim 1 , wherein n is 10.

10. The indole long-chain alcohol according to claim 1 , wherein n is 12.

11. The indole long-chain alcohol according to claim 1 , wherein n is 14.

12. The indole long-chain alcohol according to claim 1 , wherein n is 16.

13. The indole long-chain alcohol according to claim 1 , wherein n is 18.

14. A medicinal composition comprising a therapeutically effective amount of the indole long-chain alcohol according to claim 1 and a pharmaceutically acceptable carrier.

15. The medicinal composition according to claim 14 , wherein the therapeutically effective amount of the indole long-chain alcohol is from 0.001 to 1000 mg.

16. The medicinal composition according to claim 14 , wherein the medicinal composition further comprises an excipient, a binder, a disintegrator, a lubricant, a colorant, and/or a corrigent.

17. The medicinal composition according to claim 14 , wherein the medicinal composition is in the form of a tablet, a coated tablet, a granule, a coated granule, a capsule, a solution, a syrup, an elixir, an oil suspension, or an aqueous suspension.

18. A method for treating a cerebral disease comprising administering to a patient in need thereof a therapeutically effective amount of the indole long-chain alcohol according to claim 1 , wherein the cerebral disease is a dementia disease.

19. The method according to claim 18 , wherein the therapeutically effective amount of the indole long-chain alcohol is from 0.001 to 1000 mg/day.

20. The method according to claim 18 , wherein the therapeutically effective amount of the indole long-chain alcohol is administered either once per day, or in two to four divided doses per day.

21. The method according to claim 18 , wherein the therapeutically effective amount of the indole long-chain alcohol is administered orally or parenterally.

22. A method for treating a malignant tumor comprising administering to a patient in need thereof a therapeutically effective amount of the indole long-chain alcohol according to claim 1 , wherein the malignant tumor is a brain tumor.

23. The method according to claim 22 , wherein the therapeutically effective amount of the indole long-chain alcohol is from 0.001 to 1000 mg/day.

24. The method according to claim 22 , wherein the therapeutically effective amount of the indole long-chain alcohol is administered either once per day, or in two to four divided doses per day.

25. The method according to claim 22 , wherein the therapeutically effective amount of the indole long-chain alcohol is administered orally or parenterally.

26. The indole long-chain alcohol according to claim 1 , wherein n is 20.

Assignments (3)
ASSIGNMENT (PARTIAL RIGHTS) Recorded Jul 9, 2012
From: MEIJI CO., LTD.
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; UNIVERSITE DE STRASBOURG
Reel/Frame 028510/0193 →
CHANGE OF NAME Recorded Aug 9, 2011
From: MEIJI DAIRIES CORPORATION
To: MEIJI CO., LTD.
Reel/Frame 026724/0012 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2005
From: LUU, BANG; COOWAR, DJALIL; YAMADA, MASASHI; SUMA, YUKIE; SUZUKI, HIROTO
To: MEIJI DAIRIES CORPORATION
Reel/Frame 016247/0511 →
Continuity (1)
Related Publication 20050131053A1 · Jun 16, 2005